Corporate info on Sparta (3/4, unch) at spartapharma.com
Description of drug development pipeline at spartapharma.com
The Chairman of Sparta, William Sullivan, was former Chairman, President, and CEO of Burroughs Wellcome Company. Information on Burroughs Wellcome from Glaxo Wellcome website. See glaxowellcome.com
Jerry Hood, CEO, President, and Director, was former Head of Worldwide Development, SmithKline Beecham. From spartapharma.com
From 1997 Form 10K at edgar-online.com
"Furthermore, RTP and the Company may pursue a joint venture to evaluate and develop paclitaxel and related derivatives. If the terms of the joint venture are not agreed to by the end of 1997, RTP can license the rights to paclitaxel to another party."
-------
FDA applications for generic versions of paclitaxel [Taxol] are prohibited until 12/28/97, at the earliest (BioCentury, pg A1, 9/22/97). Some other suppliers of paclitaxel are listed at mypage.direct.ca under the heading "Companies."
Bristol Myers Squibb statement on Taxol at ww2.newswire.ca
Philip
Disclaimer: Invest at your own risk. Information taken from publicly available sources and is NOT guaranteed to be accurate. Information presented for discussion purposes only and not to be construed as investment advice. Do your own research. This article is neither a recommendation nor a offer to buy or sell any security whatsoever. |
